Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

SyneuRx is a global biotech company listed in Taiwan (TWSE: 6575), undergoing clinical development of new classes of drugs for multiple major CNS conditions and respiratory viral diseases like COVID-19. SyneuRx is a clinical-stage global biotech company, which is currently conducting clinical development of new classes of drugs for COVID-19 as well as multiple major CNS (Central Nervous System) disease conditions. We have s...
SyneuRx is a global biotech company listed in Taiwan (TWSE: 6575), undergoing clinical development of new classes of drugs for multiple major CNS conditions and respiratory viral diseases like COVID-19. SyneuRx is a clinical-stage global biotech company, which is currently conducting clinical development of new classes of drugs for COVID-19 as well as multiple major CNS (Central Nervous System) disease conditions. We have several early and late phase clinical trials currently in progress.

List your booth number for exhibitions, ask us